AQST News and Press, Aquestive Therapeutics Inc. From 03/09/22

Image source: The Motley Fool. Aquestive Therapeutics, Inc. (NASDAQ: AQST) Q4 2021 Earnings Call Mar 09, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Aquestive Therapeutics, Inc. (AQST) Q4 2021 Earnings Call Tran...

Aquestive Therapeutics, Inc. (AQST) Q4 2021 Earnings Conference Call March 9, 2022 08:00 ET Company Participants Bennett Watson - Investor Relations Keith Kendall - Chief Executive Officer Ernie Toth - Chief Financial Officer Dan Barber - Chief Operating Officer Conference Call Participants G...

Aquestive Therapeutics press release (NASDAQ:AQST): FY GAAP EPS of -$1.85 misses by $0.36. Revenue of $50.83M (+10.9% Y/Y) beats by $1.73M. For further details see: Aquestive Therapeutics GAAP EPS of -$1.85 misses by $0.36, revenue of $50.83M beats by $1.73M

Continues to interact with FDA regarding orphan drug review of the NDA for Libervant™ (diazepam) Buccal Film Reports start of Part 2 of EPIPHAST crossover study for AQST-109 epinephrine oral film after positive Part 1 data Enters license, development and supply agreement fo...

Suzhou antibody company Adagene will apply its masking technology to as many as four Sanofi candidates in a collaboration worth up to $2.5 billion. Huadong Medicine will acquire Asia rights (ex-Japan) for two Heidelberg Pharma ADC candidates with options on two more in a deal potentia...

Gainers: DBV Technologies (NASDAQ:DBVT) +16%. EyePoint Pharmaceuticals (NASDAQ:EYPT) +14%. Antares Pharma (NASDAQ:ATRS) +10%. Nuvalent (NASDAQ:NUVL) +8%. Aquestive Therapeutics (NASDAQ:AQST) +7%. Losers: NuCana (NASDAQ:NCNA) -54%. MediWound (NASDAQ:MDWD) -15%.&#x...

WARREN, N.J., March 03, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive”), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives...

WARREN, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, presented a late breaking p...

KAR Auction Services (NYSE:KAR) +65% on offloading ADESA U.S. Physical Auction business to Carvana for $2.2B. Farfetch (NYSE:FTCH) +30% on Q4 results. Universal Security Instruments (NYSE:UUU) +28% and Infinite Reality, Inc jointly announce merger agreement. Cyren (NA...

Aquestive Therapeutics (NASDAQ:AQST) is trading ~6% higher in the premarket Friday after the commercial-stage pharmaceutical company announced positive topline data from its Part 1 of the EPIPHAST study for AQST-109 epinephrine oral film. In the randomized open-label trial involving...